Infinitopes expands seed financing to $35 million to accelerate clinical development of precision cancer vaccine Infinitopes, a clinical-stage cancer vaccine biotechnology company, announced the successful completion of the second close of its seed financing round, securing an additional $15.4 million and bringing the total raised to $35.1 million. This latest investment was co-led by Octopus […]
As one of the organisers, Optimum is proud to partner with Anglonordic year on year to curate an awesome agenda for this fantastic event. Exclusively for European investors and R&D companies…
JPM 2026 was touted as the event that would usher in the best year in biotech in a long time. But when it happened there was a distinct lack of mega-deals to shout about. The elephant, you might say, was not in the room. Does this bode ill for 2026? Or is news of such […]
Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe The Novo Nordisk Foundation has allocated up to DKK 5.5 billion (EUR 736 million) to the BioInnovation Institute (BII), a leading institute for life science and deep tech innovation in Copenhagen. The funding will enable BII to expand its activities into […]
There’s a temptation to think we won’t need Dry January or Love Your Liver Month initiatives in the future. After all, alcohol consumption is declining across the West and has been doing so for the last two decades. Gen Z teens rebel against their Gen X parents by not drinking – and castigating their elders for their unhealthy ways. In the UK only 7% […]
